What companies are 2315.HK's competitors?

Biocytogen Pharmaceuticals (Beijing) Co., Ltd. (2315.HK)'s closest competitors are the companies in the same industry classification, listed in the Peers to Research table on this page. Click any peer ticker to open its full analysis.

How does 2315.HK compare to its peers?

The peer comparison table on this page shows Biocytogen Pharmaceuticals (Beijing) Co., Ltd. (2315.HK) alongside each peer with price, market cap, and key valuation / dividend metrics aligned side-by-side. Use it to spot relative outliers within the same business model.

What sector does 2315.HK operate in?

Biocytogen Pharmaceuticals (Beijing) Co., Ltd. (2315.HK) operates in the Biotechnology industry within the Healthcare sector. Peers are drawn from this classification — companies with similar revenue mix, cost structure, and customer demand drivers.

2315.HK

Biocytogen Pharmaceuticals (Beijing) Co., Ltd.

HKSE·Biotechnology · Healthcare

HK$51.25HK$0.55−1.06%

Market capHK$20.78B·Market closed·Jul 22 3:59 AM UTC

Frequently Asked Questions About 2315.HK

What companies are 2315.HK's competitors?: Biocytogen Pharmaceuticals (Beijing) Co., Ltd. (2315.HK)'s closest competitors are the companies in the same industry classification, listed in the Peers to Research table on this page. Click any peer ticker to open its full analysis.
How does 2315.HK compare to its peers?: The peer comparison table on this page shows Biocytogen Pharmaceuticals (Beijing) Co., Ltd. (2315.HK) alongside each peer with price, market cap, and key valuation / dividend metrics aligned side-by-side. Use it to spot relative outliers within the same business model.
What sector does 2315.HK operate in?: Biocytogen Pharmaceuticals (Beijing) Co., Ltd. (2315.HK) operates in the Biotechnology industry within the Healthcare sector. Peers are drawn from this classification — companies with similar revenue mix, cost structure, and customer demand drivers.

2315.HK

Biocytogen Pharmaceuticals (Beijing) Co., Ltd.

HKSE·Biotechnology · Healthcare

HK$51.25HK$0.55−1.06%

Market capHK$20.78B·Market closed·Jul 22 3:59 AM UTC

Peers


6699.HK	Angelalign Technology Inc.	HK$80.30	HK$13.7B
9887.HK	Nanjing Leads Biolabs Co Ltd	HK$66.40	HK$13.2B
2142.HK	HBM Holdings Limited	HK$12.67	HK$10.7B
1672.HK	Ascletis Pharma Inc.	HK$8.74	HK$9.2B
2157.HK	Lepu Biopharma Co., Ltd.	HK$4.81	HK$8.7B
2171.HK	CARsgen Therapeutics Holdings Limited	HK$14.66	HK$8.4B
2256.HK	Abbisko Cayman Limited	HK$10.73	HK$7.7B
9966.HK	Alphamab Oncology	HK$7.75	HK$7.5B
6826.HK	Shanghai Haohai Biological Technology Co., Ltd.	HK$16.67	HK$6.7B
1858.HK	Beijing Chunlizhengda Medical Instruments Co., Ltd.	HK$8.72	HK$5.2B

Frequently Asked Questions About 2315.HK

What companies are 2315.HK's competitors?: Biocytogen Pharmaceuticals (Beijing) Co., Ltd. (2315.HK)'s closest competitors are the companies in the same industry classification, listed in the Peers to Research table on this page. Click any peer ticker to open its full analysis.
How does 2315.HK compare to its peers?: The peer comparison table on this page shows Biocytogen Pharmaceuticals (Beijing) Co., Ltd. (2315.HK) alongside each peer with price, market cap, and key valuation / dividend metrics aligned side-by-side. Use it to spot relative outliers within the same business model.
What sector does 2315.HK operate in?: Biocytogen Pharmaceuticals (Beijing) Co., Ltd. (2315.HK) operates in the Biotechnology industry within the Healthcare sector. Peers are drawn from this classification — companies with similar revenue mix, cost structure, and customer demand drivers.